Relation between absorption half-life values of four novel sustained-release dosage forms of valproic acid in dogs and humans

Related Experiment Videos

M Bialer, M Friedman, J Dubrovsky

Biopharmaceutics & Drug Disposition

|September 1, 1986

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Saturable processes affecting renal clearance of cefixime in dogs.

Pharmaceutical research·2013

A comparative electrographic analysis of the effect of sec-butyl-propylacetamide on pharmacoresistant status epilepticus.

Neuroscience·2012

The effects of central nervous system-active valproic acid constitutional isomers, cyclopropyl analogs, and amide derivatives on neuronal growth cone behavior.

Molecular pharmacology·2006

The absorption, metabolism, and excretion of the novel neuromodulator RWJ-333369 (1,2-ethanediol, [1-2-chlorophenyl]-, 2-carbamate, [S]-) in humans.

Drug metabolism and disposition: the biological fate of chemicals·2006

The antiepileptic and anticancer agent, valproic acid, induces P-glycoprotein in human tumour cell lines and in rat liver.

British journal of pharmacology·2006

Progress report on new antiepileptic drugs: a summary of the Sixth Eilat Conference (EILAT VI).

Epilepsy research·2002

See all related articles